SELEPARINA

Medicinal product

(Invented) name

SELEPARINA

Active substance (s)

Nadroparino kalcio druska

Strength

3800 anti-Xa TV/0,4 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AB06, Nadroparin

Marketing authorisation holder

UAB Edupharma, Lietuva

Date of authorisation

2021-06-29

Date of renewal

Documents

1550_Seleparina_PZ.docx

1549_1551_Seleparina_2023-03-15.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Užpildytame švirkšte (0,4 ml) yra	0.4 ml
Nadroparino kalcio druska	3800 anti-Xa TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106750	92853	1092853	užpildytas švirkštas	0,4 ml N6	ASPĮ	Receptinis	LT/L/21/1550/001	Tiekiama	-	-	No	-	-	Download
107512	93617	1093617	užpildytas švirkštas	0,4 ml N10		Receptinis	LT/L/21/1550/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-06-29	Registruotas